{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:52:25Z","timestamp":1761749545366,"version":"build-2065373602"},"reference-count":112,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.path.2022.02.005","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T21:56:39Z","timestamp":1652824599000},"page":"259-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Peritoneal Pathology Review"],"prefix":"10.1016","volume":"15","author":[{"given":"Takako","family":"Kiyokawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.path.2022.02.005_bib1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/1471-0528.15692","article-title":"Influence of race\/ethnicity on prevalence and presentation of endometriosis: a systematic review and meta-analysis","volume":"126","author":"Bougie","year":"2019","journal-title":"Bjog"},{"issue":"7","key":"10.1016\/j.path.2022.02.005_bib2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.jmig.2020.01.009","article-title":"Appendiceal Endometriosis: Is Diagnosis Dependent on Pathology Evaluation? A Prospective Cohort Study","volume":"27","author":"Ross","year":"2020","journal-title":"J\u00a0Minim Invasive Gynecol"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib3","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.21873\/anticanres.14212","article-title":"Endometriosis-associated Extraovarian Malignancies: A Challenging Question for the Clinician and the Pathologist","volume":"40","author":"Gadducci","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.path.2022.02.005_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejogrb.2018.09.001","article-title":"Anatomic distribution of endometriosis: A reappraisal based on series of 1101 patients","volume":"230","author":"Audebert","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.path.2022.02.005_bib5","doi-asserted-by":"crossref","first-page":"3461209","DOI":"10.1155\/2018\/3461209","article-title":"Gastrointestinal and Urinary Tract Endometriosis: A Review on the Commonest Locations of Extrapelvic Endometriosis","volume":"2018","author":"Charatsi","year":"2018","journal-title":"Adv Med"},{"key":"10.1016\/j.path.2022.02.005_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-pathmechdis-012419-032654","article-title":"The Origin and Pathogenesis of Endometriosis","volume":"15","author":"Wang","year":"2020","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0035-1564609","article-title":"The Role of Stem Cells in the Etiology and Pathophysiology of Endometriosis","volume":"33","author":"Hufnagel","year":"2015","journal-title":"Semin Reprod Med"},{"issue":"8","key":"10.1016\/j.path.2022.02.005_bib8","first-page":"1707","article-title":"Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage","volume":"58","author":"Jiang","year":"1998","journal-title":"Cancer Res"},{"issue":"16","key":"10.1016\/j.path.2022.02.005_bib9","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/path.5314","article-title":"Oncogenic mutations in histologically normal endometrium: the new normal?","volume":"249","author":"Lac","year":"2019","journal-title":"J\u00a0Pathol"},{"issue":"8","key":"10.1016\/j.path.2022.02.005_bib11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/IGC.0b013e31826b5dcc","article-title":"Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma","volume":"22","author":"Ayhan","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"19","key":"10.1016\/j.path.2022.02.005_bib12","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-Associated Mutations in Endometriosis without Cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.path.2022.02.005_bib13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jcp.2008.064261","article-title":"Peritoneal stromal endometriosis: a detailed morphological analysis of a large series of cases of a common and under-recognised form of endometriosis","volume":"62","author":"Boyle","year":"2009","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/his.13970","article-title":"Endometriosis-related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions","volume":"76","author":"McCluggage","year":"2020","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jcp.55.5.391","article-title":"CD10 is useful in demonstrating endometrial stroma at ectopic sites and in confirming a diagnosis of endometriosis","volume":"55","author":"Sumathi","year":"2002","journal-title":"J\u00a0Clin Pathol"},{"issue":"8","key":"10.1016\/j.path.2022.02.005_bib16","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s43032-020-00189-4","article-title":"IFITM1 is a Novel, Highly Sensitive Marker for Endometriotic Stromal Cells in Ovarian and Extragenital Endometriosis","volume":"27","author":"Sun","year":"2020","journal-title":"Reprod Sci"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-8258(88)90224-7","article-title":"Gliomatosis peritonei with endometriosis externa","volume":"29","author":"Dwor\u00e1k","year":"1988","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00004347-199804000-00015","article-title":"Leiomyomatosis peritonealis disseminata, endometriosis, and multicystic mesothelioma: an unusual association","volume":"17","author":"Zotalis","year":"1998","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.path.2022.02.005_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200403000-00001","article-title":"Polypoid endometriosis: a clinicopathologic analysis of 24 cases and a review of the literature","volume":"28","author":"Parker","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pathol.2017.10.006","article-title":"Endometriosis-associated ovarian neoplasia","volume":"50","author":"Matias-Guiu","year":"2018","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004347-199601000-00001","article-title":"Prognostic importance of hyperplasia and atypia in endometriosis","volume":"15","author":"Seidman","year":"1996","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.path.2022.02.005_bib22","first-page":"318","article-title":"A\u00a0histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes","volume":"53","author":"Czernobilsky","year":"1979","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.path.2022.02.005_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2559.1997.d01-592.x","article-title":"Ovarian atypical endometriosis: its close association with malignant epithelial tumours","volume":"30","author":"Fukunaga","year":"1997","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.path.2022.02.005_bib24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/jog.13372","article-title":"New knowledge and insights about the malignant transformation of endometriosis","volume":"43","author":"Taniguchi","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"9","key":"10.1016\/j.path.2022.02.005_bib25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3109\/09513590.2014.926325","article-title":"Novel insights on the malignant transformation of endometriosis into ovarian carcinoma","volume":"30","author":"Gadducci","year":"2014","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004347-200104000-00004","article-title":"Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types","volume":"20","author":"Stern","year":"2001","journal-title":"Int J Gynecol Pathol"},{"issue":"11","key":"10.1016\/j.path.2022.02.005_bib27","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/PAS.0000000000000083","article-title":"Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases","volume":"37","author":"Masand","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00000478-199902000-00005","article-title":"Florid cystic endosalpingiosis with tumor-like manifestations: a report of four cases including the first reported cases of transmural endosalpingiosis of the uterus","volume":"23","author":"Clement","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2022.02.005_bib29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00000478-199206000-00001","article-title":"Endocervicosis of the urinary bladder. A report of six cases of a benign m\u00fcllerian lesion that may mimic adenocarcinoma","volume":"16","author":"Clement","year":"1992","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2022.02.005_bib30","first-page":"731","article-title":"M\u00fcllerianosis of the urinary bladder","volume":"9","author":"Young","year":"1996","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.path.2022.02.005_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/PGP.0000000000000600","article-title":"A\u00a0Clinicopathologic Study and Descriptive Analysis of \"Atypical Endosalpingiosis","volume":"39","author":"Talia","year":"2020","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.5353","article-title":"Oncogenic BRAF and KRAS mutations in endosalpingiosis","volume":"250","author":"Chui","year":"2020","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.path.2022.02.005_bib33","first-page":"8621570","article-title":"Florid Cystic Endosalpingiosis (M\u00fcllerianosis) in Pregnancy","volume":"2016","author":"Morales-Rosell\u00f3","year":"2016","journal-title":"Case Rep Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.path.2022.02.005_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00404-010-1700-1","article-title":"Pelvic mass-like florid cystic endosalpingiosis of the uterus: a case report and a review of literature","volume":"283","author":"Rosenberg","year":"2011","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.path.2022.02.005_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/PGP.0000000000000613","article-title":"Low-grade Serous Carcinoma Arising in Inguinal Nodal Endosalpingiosis: Report of 2 Cases and Literature Review","volume":"39","author":"Sah","year":"2020","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"10.1016\/j.path.2022.02.005_bib36","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/PAS.0b013e31825793e1","article-title":"Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma","volume":"36","author":"Djordjevic","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2022.02.005_bib37","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/PAS.0b013e3181f17d33","article-title":"Nodal endosalpingiosis in ovarian serous tumors of low malignant potential with lymph node involvement: a case for a precursor lesion","volume":"34","author":"Djordjevic","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/IGC.0b013e3181991a49","article-title":"Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors)","volume":"19","author":"Fadare","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.path.2022.02.005_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00000478-199003000-00004","article-title":"Serous borderline tumors of the peritoneum","volume":"14","author":"Bell","year":"1990","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2022.02.005_bib40","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/jcp.2005.027946","article-title":"Serous adenocarcinoma of the sigmoid mesentery arising in cystic endosalpingiosis","volume":"58","author":"McCoubrey","year":"2005","journal-title":"J\u00a0Clin Pathol"},{"issue":"6","key":"10.1016\/j.path.2022.02.005_bib41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/his.13324","article-title":"The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei","volume":"71","author":"Carr","year":"2017","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A\u00a0Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000658-199402000-00001","article-title":"Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon","volume":"219","author":"Sugarbaker","year":"1994","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","article-title":"Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","volume":"47","author":"Govaerts","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.path.2022.02.005_bib45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/jclinpath-2012-200843","article-title":"Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases","volume":"65","author":"Carr","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2022.02.005_bib46","series-title":"WHO Classification of Tumours Editorial Board. Female genital tumours","first-page":"211","article-title":"Pseudomyxoma peritonei","author":"Misdraji","year":"2020"},{"key":"10.1016\/j.path.2022.02.005_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12967-015-0485-1","article-title":"BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma","volume":"13","author":"Alakus","year":"2015","journal-title":"J\u00a0Transl Med"},{"issue":"4","key":"10.1016\/j.path.2022.02.005_bib48","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/bjc.2013.47","article-title":"Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms","volume":"108","author":"Nishikawa","year":"2013","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.path.2022.02.005_bib49","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.humpath.2014.04.018","article-title":"GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival","volume":"45","author":"Singhi","year":"2014","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib50","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jmoldx.2018.05.002","article-title":"Analysis of Mutation and Loss of Heterozygosity by Whole-Exome Sequencing Yields Insights into Pseudomyxoma Peritonei","volume":"20","author":"Pengelly","year":"2018","journal-title":"J\u00a0Mol Diagn"},{"issue":"7","key":"10.1016\/j.path.2022.02.005_bib51","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1373\/clinchem.2014.225565","article-title":"Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations","volume":"60","author":"Liu","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.path.2022.02.005_bib52","unstructured":"Misdraji J, Carr NJ, Pai RK, et al. Appendiceal mucinous neoplasms. In: WHO Classification of Tumours Editorial Board. Digestive system tumours. Lyon (France): International Agency for Research on Cancer; 2018. pp. 144-146. (WHO classification of tumours series, 5th ed.)."},{"issue":"3","key":"10.1016\/j.path.2022.02.005_bib53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/his.13986","article-title":"Mutation profile of high-grade appendiceal mucinous neoplasm","volume":"76","author":"Liao","year":"2020","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.path.2022.02.005_bib54","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/DCR.0000000000000869","article-title":"Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy","volume":"60","author":"Mehta","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.path.2022.02.005_bib55","series-title":"WHO Classification of Tumours Editorial Board. Digestive system tumours","first-page":"144","article-title":"Appendiceal mucinous neoplasms","author":"Misdraji","year":"2018"},{"issue":"3","key":"10.1016\/j.path.2022.02.005_bib56","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PGP.0000000000000238","article-title":"Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining","volume":"35","author":"Strickland","year":"2016","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.path.2022.02.005_bib57","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e31802efb45","volume":"31","author":"Vang","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2022.02.005_bib58","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/PAS.0b013e3181abe31b","article-title":"Ruptured appendiceal diverticula mimicking low-grade appendiceal mucinous neoplasms","volume":"33","author":"Hsu","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib59","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1097\/PAS.0000000000001662","article-title":"The Frontiers of Appendiceal Controversies: Mucinous Neoplasms and Pseudomyxoma Peritonei","volume":"46","author":"Hissong","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2022.02.005_bib60","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00000478-200308000-00006","article-title":"Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases","volume":"27","author":"Misdraji","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2022.02.005_bib61","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s11605-019-04239-4","article-title":"Outcomes Following Cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-Year Experience","volume":"24","author":"Narasimhan","year":"2020","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib62","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1245\/s10434-015-4995-0","volume":"23","author":"Ihemelandu","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib63","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1245\/s10434-018-7007-3","article-title":"Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy","volume":"26","author":"Munoz-Zuluaga","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.path.2022.02.005_bib64","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAS.0000000000001418","article-title":"Malignant Diffuse Mesothelioma in Women: A Study of 354 Cases","volume":"44","author":"Pavlisko","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PAS.0000000000001545","article-title":"Malignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 Cases","volume":"45","author":"Malpica","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib66","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1309\/2H0NVRERPP2LJDUA","article-title":"Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis","volume":"123","author":"Baker","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"28","key":"10.1016\/j.path.2022.02.005_bib67","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","article-title":"Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib68","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/modpathol.2016.188","article-title":"Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X","volume":"30","author":"Joseph","year":"2017","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2022.02.005_bib69","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jtho.2016.12.019","article-title":"BAP1 Is Altered by Copy Number Loss, Mutation, and\/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas","volume":"12","author":"Leblay","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi","year":"2016","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.path.2022.02.005_bib71","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/PAS.0000000000000935","article-title":"PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma","volume":"41","author":"Chapel","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5858\/arpa.2017-0092-OA","article-title":"Immunohistochemistry in peritoneal mesothelioma: a single-center experience of 244 cases","volume":"142","author":"Tandon","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib73","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1309\/AJCP0B3YJBXWXJII","article-title":"Value of claudin-4 immunostaining in the diagnosis of mesothelioma","volume":"139","author":"Ordonez","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.pap.0000201832.15591.1d","article-title":"Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update","volume":"13","author":"Ordonez","year":"2006","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2012.05.014","article-title":"Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update","volume":"44","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.path.2022.02.005_bib77","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/PAS.0000000000001565","article-title":"The Separation of Benign and Malignant Mesothelial Proliferations: New Markers and How to Use Them","volume":"44","author":"Churg","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"40","key":"10.1016\/j.path.2022.02.005_bib78","doi-asserted-by":"crossref","first-page":"68863","DOI":"10.18632\/oncotarget.20317","article-title":"Diagnostic accuracy of BRCA1-associated protein 1 in malignant mesothelioma: a meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib79","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/PAS.0000000000000616","article-title":"BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2022.02.005_bib80","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","article-title":"Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas","volume":"142","author":"Berg","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.path.2022.02.005_bib81","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/modpathol.2009.186","article-title":"CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival","volume":"23","author":"Krasinskas","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2022.02.005_bib82","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma","volume":"33","author":"Chapel","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib84","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","article-title":"Malignant mesothelioma in situ: morphologic features and clinical outcome","volume":"33","author":"Churg","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib85","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/ijms12021334","article-title":"Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation","volume":"12","author":"Boylan","year":"2011","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib86","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2022.02.005_bib87","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.humpath.2015.03.008","article-title":"Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium","volume":"46","author":"Iwamoto","year":"2015","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.path.2022.02.005_bib88","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.humpath.2005.08.008","article-title":"Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas","volume":"36","author":"Ordonez","year":"2005","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib89","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/PAT.0000000000000223","article-title":"Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours","volume":"47","author":"Fadare","year":"2015","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.path.2022.02.005_bib90","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s12253-009-9170-0","article-title":"Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma","volume":"15","author":"Chua","year":"2009","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.path.2022.02.005_bib91","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2015.12.012","article-title":"Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma","volume":"51","author":"Andrici","year":"2016","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.path.2022.02.005_bib92","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1309\/AJCPOATJ9L4GCGDA","article-title":"p16\/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer","volume":"143","author":"Ito","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.path.2022.02.005_bib93","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1699-0463.1990.tb05015.x","article-title":"Estrogen and progesterone receptors in epithelial ovarian tumours","volume":"98","author":"Glavind","year":"1990","journal-title":"Apmis"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib94","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004347-199301000-00007","article-title":"Florid mesothelial hyperplasia associated with ovarian tumors: a potential source of error in tumor diagnosis and staging","volume":"12","author":"Clement","year":"1993","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.path.2022.02.005_bib95","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/PGP.0000000000000146","article-title":"Selected topics in peritoneal pathology","volume":"33","author":"Baker","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2022.02.005_bib96","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.2147\/CMAR.S170300","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations","volume":"11","author":"Enomoto","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"11","key":"10.1016\/j.path.2022.02.005_bib97","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.5858\/2006-130-1654-PSOHPI","article-title":"Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma","volume":"130","author":"Cerruto","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib98","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","article-title":"Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib99","doi-asserted-by":"crossref","first-page":"633","DOI":"10.21873\/invivo.11521","article-title":"Clinicopathological Characteristics of Well-differentiated Papillary Mesothelioma of The Peritoneum: A Single-institutional Experience of 12 Cases","volume":"33","author":"Kim","year":"2019","journal-title":"Vivo"},{"issue":"4","key":"10.1016\/j.path.2022.02.005_bib100","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00000478-200404000-00013","article-title":"Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases","volume":"28","author":"Galateau-Salle","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib101","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAS.0b013e3182354a79","article-title":"Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases","volume":"36","author":"Malpica","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.005_bib102","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/1097-0142(19900115)65:2<292::AID-CNCR2820650218>3.0.CO;2-W","article-title":"Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases","volume":"65","author":"Daya","year":"1990","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41379-018-0127-2","article-title":"Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42","volume":"32","author":"Stevers","year":"2019","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2022.02.005_bib104","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAP.0000000000000278","article-title":"Adenomatoid Tumor: A Review of Pathology With Focus on Unusual Presentations and Sites, Histogenesis, Differential Diagnosis, and Molecular and Clinical Aspects With a Historic Overview of Its Description","volume":"27","author":"Karpathiou","year":"2020","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"10.1016\/j.path.2022.02.005_bib105","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jcp.2005.035386","article-title":"Multiple adenomatoid tumours in the liver and peritoneum","volume":"60","author":"Hayes","year":"2007","journal-title":"J\u00a0Clin Pathol"},{"issue":"11","key":"10.1016\/j.path.2022.02.005_bib106","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1600-0463.2008.01084.x","article-title":"Multiple extragenital adenomatoid tumors in the mesocolon and omentum","volume":"116","author":"Yeh","year":"2008","journal-title":"Apmis"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib107","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/1097-0142(197905)43:5<1678::AID-CNCR2820430518>3.0.CO;2-N","article-title":"Extragenital adenomatoid tumor: Evidence for the mesothelial theory of origin","volume":"43","author":"Craig","year":"1979","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.path.2022.02.005_bib108","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1308\/003588411X13008844892887","article-title":"Transmural peritoneal adenomatoid tumour in the ileocaecal region causing massive haemoperitoneum and low gastrointestinal bleeding: differential diagnosis with capillary haemangiomas","volume":"93","author":"Ruiz-Tovar","year":"2011","journal-title":"Ann R Coll Surg Engl"},{"issue":"4","key":"10.1016\/j.path.2022.02.005_bib109","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/modpathol.2017.153","article-title":"Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation","volume":"31","author":"Goode","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.005_bib110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/PAI.0000000000000700","article-title":"BAP1 Loss is a Useful Adjunct to Distinguish Malignant Mesothelioma Including the Adenomatoid-like Variant\u00a0From Benign Adenomatoid Tumors","volume":"28","author":"Erber","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6","key":"10.1016\/j.path.2022.02.005_bib111","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00404-018-4728-2","article-title":"Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? A systematic review to find an evidence-based management","volume":"297","author":"Rapisarda","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.path.2022.02.005_bib112","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/OGX.0b013e31819f93d4","article-title":"Peritoneal inclusion cysts: a review","volume":"64","author":"Vallerie","year":"2009","journal-title":"Obstet Gynecol Surv"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918122000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918122000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:44:34Z","timestamp":1761749074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918122000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1875918122000150"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2022.02.005","relation":{},"ISSN":["1875-9181"],"issn-type":[{"type":"print","value":"1875-9181"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritoneal Pathology Review","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2022.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}